http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20050053599-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a4b478b2de0b6e2003167732f7d4a7b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2003-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ad718ae01ac605c71e887715bffdd2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df5d94f9f500f9f7ad000ea03163eb59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6e50103cf521f900d745045f40d10c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94aa3b7b903921e0d595653927f18af5 |
| publicationDate | 2005-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20050053599-A |
| titleOfInvention | Total synthesis of myriaporones |
| abstract | The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, derivative, prodrug, or stereoisomer thereof:n n n [Formula I]n n n n n n n n In the above formula,n n n Each substituent R is independently H, SiR ' 3 , SOR', SO 2 X, C (= 0) R ', C (= 0) OR', C (= 0) NR ', substituted or unsubstituted alkyl, Substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, aryl, heteroaryl, or aralkyl;n n n Substituent R ′ is selected from substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, aminoalkyl, aryl, aralkyl, and heterocyclic groups,n n n Substituent R "is H, OH, OR ', OCOR', SH, SR ', SOR', SO 2 R ', NO 2 , NH 2 , NHR', N (R ') 2 , NHCOR', N (COR ' ) 2 , NHSO 2 R ', CN, halogen, C (= 0) H, C (= 0) R', CO 2 H, CO 2 R ', CH 2 OR, substituted or unsubstituted alkyl, substituted or unsubstituted Substituted haloalkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkylidene, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted aralkyl, and substituted or unsubstituted Selected from the group consisting of heteroaromatics,n n n Provided that the compound is not compound (1), (3), or (4) of US Pat. No. 5,514,708. The compound has antitumor activity. The present invention also provides a method for synthesizing the compound. |
| priorityDate | 2002-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 143.